Drugs / MK2295
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00387140 | Oct 2006 → May 2007 | neuropathy, painful | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MK2295 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00387140 ↗ |
| Action | Inhibit | “Vanilloid receptor antagonist” CHEMBL214796 ↗ |
| Modality | Small molecule | — CHEMBL214796 ↗ |
| Target | TRPV1 | “Vanilloid receptor antagonist” CHEMBL214796 ↗ |